Suppressing serum response factor inhibits invasion in cervical cancer cell lines via regulating egr‑1 and epithelial‑mesenchymal transition

11Citations
Citations of this article
9Readers
Mendeley users who have this article in their library.

Abstract

Serum response factor (SRF) is a transcription factor that has important roles in tumor progression. However, its role in cervical cancer cell proliferation and invasion remains unclear. The present study revealed that SRF silencing constrained cervical cancer cell proliferation and invasion via controlling early growth response-1 (Egr-1). The results demonstrated that SRF was significantly increased in cervical cancer tissues and cell lines, compared with normal. Suppressing SRF, by using a loss-of-function experiment, constrained cervical cancer cell proliferation, invasion, and epithelial-mesenchymal transition. Furthermore, SRF knockdown significantly downregulated Egr-1 expression in cervical cancer cell lines, and overexpression of Egr-1 reversed the effect of SRF on cell proliferation, invasion, and epithelial-mesenchymal transition. Therefore, SRF may control cell proliferation and invasion by regulating Egr-1 in cervical cancer.

Cite

CITATION STYLE

APA

Ma, L., Yu, Y., & Qu, X. (2019). Suppressing serum response factor inhibits invasion in cervical cancer cell lines via regulating egr‑1 and epithelial‑mesenchymal transition. International Journal of Molecular Medicine, 43(1), 614–620. https://doi.org/10.3892/ijmm.2018.3954

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free